22 July 2021 (Thursday) - Transfusion News Update

The latest update from the nice people at “Transfusion News” arrived in my in-box this morning. All useful stuff…

Platelet-Rich Plasma Injections Do Not Reduce Tendon Dysfunction in Patients with Chronic Midportion Achilles Tendinopathy

July 21, 2021
HaChronic midportion Achilles tendinopathy is caused by a breakdown of the cartilage in the middle of the Achilles tendon, resulting in painful swelling and limited physical activity. Current treatments include nonsteroidal anti-inflammatory drugs, exercise to strengthen and stretch the tendon, and injections to help the tendon heal. Autologous platelet-rich plasma (PRP) is often injected into the tendon to infuse the Achilles tendon with a high concentration of growth factors to promote regeneration of the tendon.[Read More]


Plasma Exchange for Refractory Vaccine-Induced Immune Thrombotic Thrombocytopenia

July 14, 2021
Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a very rare side effect that can occur 5 to 30 days after immunization with the Astra Zeneca ChAdOx1 nCoV-19 vaccine. VITT has a mortality rate of approximately 30-60%. VITT is characterized by heparin-independent platelet factor 4 (PF4) antibodies, and first-line treatments include non-heparin anticoagulants and high dose intravenous immune globulin (IVIG). [Read More]

No comments:

Post a Comment